NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Viscosupplementation (Orthopedic Devices) - Global Market Analysis and Forecast ModelRead the full report: https://www.reportlinker.com/p05588802
SummaryViscosupplementation (Orthopedic Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of Musculoskeletal Disability around the world.Osteoarthritis (OA) is characterized by the degradation of the affected joint's cartilage and bone hypertrophy; this disability is accompanied by joint pain, stiffness, and loss of range of motion.Initially treated with various therapies including physical therapy and non-steroidal anti-inflammatory drugs (NSAIDs), advanced cases of Osteoarthritis (OA) have traditionally been treated surgically.However, intra-articular Viscosupplementation with Hyaluronic Acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to joint replacement surgery in the symptomatic management of Osteoarthritis (OA) over the past decade.Viscosupplementation is primarily used in one, three, and five-injection treatment regimens.Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).Moreover, analyst comments with qualitative insight offer context for quantitative data.Key Inclusions of the market modelCurrently marketed viscosupplementation products and evolving competitive landscape -- Insightful review of the key industry trends.- Annualized viscosupplementation market revenue by segment and market outlooks from 2015-2028.- Granular data on total procedures, units, average selling prices and market values by segment.Global, Regional and Country level market specific insights -- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.- SWOT analysis for viscosupplementation market.- Competitive dynamics insights and trends provided for viscosupplementation market.Understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.- Country specific overview of the healthcare system.- Country specific reimbursement policies.- Country specific medtech regulatory landscape.Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.Companies covered: Ferring Pharmaceuticals, Sanofi, Fidia farmaceutici, Anika Therapeutics, Seikagaku, Chugai Pharmaceutical , OthersCountries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.ScopeThis Market Model gives important, expert insight you won't find in any other source.The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -- CMO executives who must have deep understanding of the viscosupplementation marketplace to make strategic planning and investment decisions.- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.Reasons to buyThe model will enable you to -- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Track device sales in the global and country-specific viscosupplementation market from 2015-2028.- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: https://www.reportlinker.com/p05588802
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/viscosupplementation-orthopedic-devices---global-market-analysis-and-forecast-model-300733086.html
SOURCE Reportlinker
